EA
Emerald Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1M | Buy |
53,108
+5,199
| +11% | +$1.57M | 0.59% | 68 |
|
|
2025
Q1 | $15.9M | Buy |
47,909
+20,643
| +76% | +$6.84M | 0.71% | 57 |
|
|
2024
Q4 | $8.41M | Buy |
27,266
+1
| +0% | +$309 | 0.33% | 91 |
|
|
2024
Q3 | $5.79M | Sell |
27,265
-69,499
| -72% | -$14.7M | 0.22% | 109 |
|
|
2024
Q2 | $27.1M | Sell |
96,764
-4,859
| -5% | -$1.36M | 1.14% | 28 |
|
|
2024
Q1 | $27.1M | Buy |
101,623
+53,901
| +113% | +$14.4M | 1.09% | 29 |
|
|
2023
Q4 | $11M | Buy |
47,722
+46,844
| +5,335% | +$10.8M | 0.47% | 85 |
|
|
2023
Q3 | $128K | Sell |
878
-60,605
| -99% | -$8.85M | 0.01% | 212 |
|
|
2023
Q2 | $14.2M | Sell |
61,483
-20,581
| -25% | -$4.75M | 0.62% | 75 |
|
|
2023
Q1 | $19.9M | Buy |
82,064
+69,076
| +532% | +$16.7M | 0.95% | 37 |
|
|
2022
Q4 | $3.77M | Buy |
+12,988
| New | +$3.77M | 0.18% | 110 |
|